Oruka Therapeutics, Inc.
ORKANasdaqCIK 907654HealthcareFiscal year ends Dec 31
Reports and events: 389 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-10-2608:00 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-26-112281 |
| 2026-08-2416:06 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001213900-26-093021 |
| 2026-08-1016:06 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001213900-26-087231 |
| 2026-08-1007:00 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001213900-26-086933 |
| 2026-07-0121:30 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001104659-26-080010 |
| 2026-06-0416:15 ET | 8-K | 5.07 Shareholder vote results | 0001213900-26-065294 |
| 2026-06-0116:01 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-26-063481 |
| 2026-05-1316:01 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001213900-26-055769 |
| 2026-05-0418:00 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001104659-26-055049 |
| 2026-04-3016:17 ET | 8-K | 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-26-050249 |
| 2026-04-2708:00 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-26-047743 |
| 2026-04-1716:10 ET | DEF 14A | Proxy statementPeriod 2026-06-02 | 0001213900-26-045159 |
| 2026-03-1216:03 ET | 10-K | Annual reportPeriod 2025-12-31 | 0001213900-26-026929 |
| 2025-12-1116:10 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001213900-25-120676 |
| 2025-11-1216:02 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001213900-25-109182 |
| 2025-09-2216:26 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-25-090129 |
| 2025-09-1918:56 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001104659-25-091774 |
| 2025-08-1116:01 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0001213900-25-074281 |
| 2025-07-0116:01 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001213900-25-060352 |
| 2025-06-0316:00 ET | 8-K | 5.07 Shareholder vote results | 0001213900-25-050756 |
| 2025-05-1416:02 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0001213900-25-043279 |
| 2025-04-1815:00 ET | DEF 14A | Proxy statementPeriod 2025-06-02 | 0001213900-25-033316 |
| 2025-03-1019:00 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001213900-25-022364 |
| 2025-03-0616:02 ET | 10-K | Annual reportPeriod 2024-12-31 | 0001213900-25-021165 |
| 2025-02-0516:00 ET | 8-K | 1.01 Entry into a material agreement | 0001213900-25-010525 |
| 2024-12-1907:16 ET | 8-K | 1.01 Entry into a material agreement | 0001213900-24-110303 |
| 2024-11-2118:30 ET | SC 13D/A | Ownership report, active investor, amended | 0001213900-24-101117 |
| 2024-11-1816:10 ET | 8-K | 5.07 Shareholder vote results | 0001213900-24-099645 |
| 2024-11-1416:56 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-24-098530 |
| 2024-11-1406:37 ET | S-1 | Registration statement | 0001213900-24-097737 |
| 2024-11-1316:01 ET | 10-Q | Quarterly reportPeriod 2024-09-30 | 0001213900-24-097443 |
| 2024-10-2216:15 ET | SC 13D/A | Ownership report, active investor, amended | 0000902664-24-005943 |
| 2024-10-1816:11 ET | DEF 14A | Proxy statementPeriod 2024-11-14 | 0001140361-24-043698 |
| 2024-10-0416:05 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001213900-24-085543 |
| 2024-09-1316:57 ET | SC 13D/A | Ownership report, active investor, amended | 0001213900-24-078635 |
| 2024-09-1316:02 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 5.03 Amendment to articles or bylaws; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-24-078549 |
| 2024-09-0617:08 ET | SC 13D | Ownership report, active investor | 0001213900-24-076599 |
| 2024-09-0517:18 ET | 8-K | 1.01 Entry into a material agreement; 2.01 Completion of an acquisition or disposition; 2.02 Results of operations; 3.03 Change to security holders’ rights; 4.01 Change of auditor; 5.01 Change in control; 5.02 Departure or appointment of officers or directors; 5.03 Amendment to articles or bylaws; 5.05 Item not in the standard list; 5.06 Item not in the standard list; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-24-076184 |
| 2024-08-2719:51 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-24-072683 |
| 2024-08-2316:35 ET | 8-K | 5.07 Shareholder vote results; 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-24-072251 |
| 2024-08-1616:25 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-24-070263 |
| 2024-08-1516:15 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001213900-24-069662 |
| 2024-08-0116:25 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-089329 |
| 2024-08-0116:05 ET | 10-Q | Quarterly reportPeriod 2024-06-30 | 0000950170-24-089246 |
| 2024-07-0917:01 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001213900-24-060156 |
| 2024-04-2516:25 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-048364 |
| 2024-04-2516:15 ET | 10-Q | Quarterly reportPeriod 2024-03-31 | 0000950170-24-048329 |
| 2024-04-2316:20 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0000950170-24-046918 |
| 2024-04-0516:05 ET | SC 13D | Ownership report, active investor | 0000902664-24-002769 |
| 2024-04-0416:30 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0000950170-24-041846 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 26, 2026, 08:01 ET. Listed shows no prices and gives no investment advice.